Jeffrey P. George

Board Director

Director

Amneal Pharmaceuticals, Inc.908 Devices Inc.LENZ Therapeutics, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 1 buy · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€43k

▼ Sales (0 ops.)

—

Latest filing published 30 Mar 2026 for LENZ Therapeutics, Inc., €43k. Read the official filing

Filing timeline

BuySale

Jeffrey P. George

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-37.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Jeffrey P. George: trading record in brief

Jeffrey P. George is a declared insider at 3 companies (board member); the most frequent names are 908 Devices Inc., Amneal Pharmaceuticals, Inc. and LENZ Therapeutics, Inc. The record holds 13 filings, for trades running from 6 May 2021 to 27 March 2026.

No open-market sale appears; the market trades are 1 purchase worth €43k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 12 option exercises. 2026 to date brings 1 purchase and no sales.

On 30 March 2026 came the latest disclosure, an open-market purchase for €43k in LENZ Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.